News Roundup: March 27-31

Article

Your weekly roundup of the latest news from Drug Topics®.

Higher Dose of Oral Semaglutide More Effective for Patients With T2D

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

Read More

Rezafungin for Injection to Treat Candidemia and Invasive Candidiasis Gets FDA Approval


The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.


Read More

Studying the Impact of Automated Insulin Delivery on Patients With Type 1 and Type 2 Diabetes

Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.

Read More

Pharmacy Practitioners Describe Experiences With COVID-19 Misinformation


COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.

Read More


Video: Tips for Medication Management During Ramadan

Pharmacists can provide support and guidance to patients during their month of fasting.


Read More


Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Image Credit: troyanphoto - stock.adobe.com
Image Credit: Michelle - stock.adobe.com
2 experts are featured in this series
© 2025 MJH Life Sciences

All rights reserved.